No
|
TR-206
|
96-12-8 |
1,2-Dibromo-3-chloropropane |
Rats |
F344/N |
Female |
Inhalation |
Adrenal Gland Cortex
|
Positive |
Positive |
ADENOMA 0/50 7/50 5/48
|
Neoplastic Lesions
|
No
|
TR-206
|
96-12-8 |
1,2-Dibromo-3-chloropropane |
Mice |
B6C3F1 |
Female |
Inhalation |
Lung
|
Positive |
Positive |
ALVEOLAR/BRONCHIOLAR ADENOMA 3/49 3/49 10/47; ALVEOLAR/BRONCHIOLAR CARCINOMA 1/49 2/49 4/47
|
Neoplastic Lesions
|
No
|
TR-206
|
96-12-8 |
1,2-Dibromo-3-chloropropane |
Mice |
B6C3F1 |
Male |
Inhalation |
Lung
|
Positive |
Positive |
ALVEOLAR/BRONCHIOLAR ADENOMA 0/41 1/40 6/45; ALVEOLAR/BRONCHIOLAR CARCINOMA 0/41 2/40 1/45
|
Neoplastic Lesions
|
Yes
|
TR-206
|
96-12-8 |
1,2-Dibromo-3-chloropropane |
Mice |
B6C3F1 |
Female |
Inhalation |
Nasal Cavity
|
Positive |
Positive |
BENIGN AND MALIGNANT TUMORS 0/50 11/50 38/50
|
Neoplastic Lesions
|
Yes
|
TR-206
|
96-12-8 |
1,2-Dibromo-3-chloropropane |
Mice |
B6C3F1 |
Male |
Inhalation |
Nasal Cavity
|
Positive |
Positive |
BENIGN AND MALIGNANT TUMORS 0/45 1/42 21/48
|
Neoplastic Lesions
|
Yes
|
TR-206
|
96-12-8 |
1,2-Dibromo-3-chloropropane |
Rats |
F344/N |
Female |
Inhalation |
Nasal Cavity
|
Positive |
Positive |
BENIGN AND MALIGNANT TUMORS 1/50 21/50 32/50
|
Neoplastic Lesions
|
Yes
|
TR-206
|
96-12-8 |
1,2-Dibromo-3-chloropropane |
Rats |
F344/N |
Male |
Inhalation |
Nasal Cavity
|
Positive |
Positive |
BENIGN AND MALIGNANT TUMORS 0/50 32/50 39/49
|
Neoplastic Lesions
|
No
|
TR-206
|
96-12-8 |
1,2-Dibromo-3-chloropropane |
Rats |
F344/N |
Female |
Inhalation |
Oral Cavity
|
Positive |
Positive |
SQUAMOUS CELL PAPILLOMA 0/50 3/50 11/50; SQUAMOUS CELL CARCINOMA 0/50 1/50 5/50
|
Neoplastic Lesions
|
No
|
TR-206
|
96-12-8 |
1,2-Dibromo-3-chloropropane |
Rats |
F344/N |
Male |
Inhalation |
Oral Cavity
|
Positive |
Positive |
SQUAMOUS CELL PAPILLOMA 0/50 1/50 8/49; SQUAMOUS CELL CARCINOMA 0/50 0/50 3/49
|
Neoplastic Lesions
|
No
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Mice |
B6C3F1 |
Female |
Inhalation |
Lung
|
Positive |
Positive |
ALVEOLAR/BRONCHIOLAR ADENOMA 3/49 7/49 13/50; ALVEOLAR/BRONCHIOLAR CARCINOMA 1/49 5/49 37/50
|
Neoplastic Lesions
|
No
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Mice |
B6C3F1 |
Male |
Inhalation |
Lung
|
Positive |
Positive |
ALVEOLAR/BRONCHIOLAR ADENOMA 0/41 0/48 11/46; ALVEOLAR/BRONCHIOLAR CARCINOMA 0/41 3/48 19/46
|
Neoplastic Lesions
|
No
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Rats |
F344/N |
Female |
Inhalation |
Lung
|
Positive |
Positive |
ALVEOLAR/BRONCHIOLAR ADENOMA 0/50 0/48 1/47 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/50 0/48 4/47 COMBINED 0/50 0/48 5/47
|
Neoplastic Lesions
|
No
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Mice |
B6C3F1 |
Female |
Inhalation |
Mammary Gland
|
Positive |
Positive |
ADENOCARCINOMA 2/50 14/50 8/50
|
Neoplastic Lesions
|
No
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Rats |
F344/N |
Female |
Inhalation |
Mammary Gland
|
Positive |
Positive |
FIBROADENOMA 4/50 29/50 24/50
|
Neoplastic Lesions
|
No
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Rats |
F344/N |
Male |
Inhalation |
Mesothelium (Abdominal Cavity/Tunica Vaginalis)
|
Positive |
Positive |
MESOTHELIOMA 0/50 7/50 25/50
|
Neoplastic Lesions
|
Yes
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Mice |
B6C3F1 |
Female |
Inhalation |
Nasal Cavity
|
Positive |
Positive |
CARCINOMA 0/50 0/50 6/50
|
Neoplastic Lesions
|
Yes
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Rats |
F344/N |
Female |
Inhalation |
Nasal Cavity
|
Positive |
Positive |
ADENOMA 0/50 11/50 3/50; ADENOCARCINOMA 0/50 20/50 29/50; CARCINOMA 0/50 0/50 25/50
|
Neoplastic Lesions
|
Yes
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Rats |
F344/N |
Male |
Inhalation |
Nasal Cavity
|
Positive |
Positive |
ADENOMA 0/50 11/50 0/50; ADENOCARCINOMA 0/50 20/50 28/50; CARCINOMA 0/50 0/50 21/50
|
Neoplastic Lesions
|
No
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Mice |
B6C3F1 |
Female |
Inhalation |
Subcutaneous Tissue
|
Positive |
Positive |
FIBROSARCOMA 0/50 5/50 11/50
|
Neoplastic Lesions
|
No
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Mice |
B6C3F1 |
Female |
Inhalation |
Vascular System (Unspecified)
|
Positive |
Positive |
HEMANGIOSARCOMA 0/50 11/50 23/50
|
Neoplastic Lesions
|
No
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Rats |
F344/N |
Female |
Inhalation |
Vascular System (Unspecified)
|
Positive |
Positive |
HEMANGIOSARCOMA 0/50 0/50 5/50
|
Neoplastic Lesions
|
No
|
TR-210
|
106-93-4 |
1,2-Dibromoethane |
Rats |
F344/N |
Male |
Inhalation |
Vascular System (Unspecified)
|
Positive |
Positive |
HEMANGIOSARCOMA 0/50 1/50 15/50
|
Neoplastic Lesions
|
No
|
TR-329
|
106-88-7 |
1,2-Epoxybutane |
Rats |
F344/N |
Male |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 0/50 1/50 1/49 OR ALVEOLAR/BRONCHIOLR CARCINOMA 0/50 1/50 4/49 COMBINED 0/50 2/50 5/49
|
Neoplastic Lesions
|
Yes
|
TR-329
|
106-88-7 |
1,2-Epoxybutane |
Rats |
F344/N |
Male |
Inhalation |
Nasal Cavity
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 0/50 7/50
|
Neoplastic Lesions
|
No
|
TR-329
|
106-88-7 |
1,2-Epoxybutane |
Rats |
F344/N |
Female |
Inhalation |
Nasal Cavity
|
Equivocal Evidence |
Equivocal Evidence |
ADENOMA 0/50 0/50 2/50
|
Neoplastic Lesions
|
Yes
|
TR-267
|
75-56-9 |
1,2-Propylene oxide |
Rats |
F344/N |
Female |
Inhalation |
Nasal Cavity
|
Some Evidence |
Some Evidence |
ADENOMA 0/50 0/50 3/50
|
Neoplastic Lesions
|
Yes
|
TR-267
|
75-56-9 |
1,2-Propylene oxide |
Rats |
F344/N |
Male |
Inhalation |
Nasal Cavity
|
Some Evidence |
Some Evidence |
ADENOMA 0/50 0/50 2/50
|
Neoplastic Lesions
|
No
|
TR-267
|
75-56-9 |
1,2-Propylene oxide |
Mice |
B6C3F1 |
Female |
Inhalation |
Vascular System (Nasal Cavity)
|
Clear Evidence |
Clear Evidence |
HEMANGIOMA 0/50 0/50 3/50; HEMANGIOSARCOMA 0/50 0/50 2/50
|
Neoplastic Lesions
|
No
|
TR-267
|
75-56-9 |
1,2-Propylene oxide |
Mice |
B6C3F1 |
Male |
Inhalation |
Vascular System (Nasal Cavity)
|
Clear Evidence |
Clear Evidence |
HEMANGIOMA 0/50 0/50 5/50; HEMANGIOSARCOMA 0/50 0/50 5/50
|
Neoplastic Lesions
|
No
|
TR-080
|
123-91-1 |
1,4-Dioxane |
Mice |
B6C3F1 |
Female |
Dosed-Water |
Liver
|
Positive |
Positive |
(CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-080
|
123-91-1 |
1,4-Dioxane |
Mice |
B6C3F1 |
Male |
Dosed-Water |
Liver
|
Positive |
Positive |
(CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-080
|
123-91-1 |
1,4-Dioxane |
Rats |
Osborne Mendel |
Female |
Dosed-Water |
Liver
|
Positive |
Positive |
(ADENOMA)
|
Neoplastic Lesions
|
Yes
|
TR-080
|
123-91-1 |
1,4-Dioxane |
Rats |
Osborne Mendel |
Female |
Dosed-Water |
Nasal Cavity
|
Positive |
Positive |
(SQUAMOUS CELL CARCINOMA)
|
Neoplastic Lesions
|
Yes
|
TR-080
|
123-91-1 |
1,4-Dioxane |
Rats |
Osborne Mendel |
Male |
Dosed-Water |
Nasal Cavity
|
Positive |
Positive |
(SQUAMOUS CELL CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-593
|
431-03-8 |
2,3-Butanedione |
Mice |
B6C3F1 |
Female |
Inhalation |
Nasal Cavity
|
Equivocal Evidence |
Equivocal Evidence |
adenocarcinoma (0/50, 0/50, 0/50, 2/50)
|
May Have Been Related
|
Yes
|
TR-593
|
431-03-8 |
2,3-Butanedione |
Rats |
Wistar Han |
Female |
Inhalation |
Nasal Cavity
|
Some Evidence |
Some Evidence |
squamous cell carcinoma (0/50, 0/50, 0/50, 3/50)
|
Neoplastic Lesions
|
Yes
|
TR-593
|
431-03-8 |
2,3-Butanedione |
Rats |
Wistar Han |
Male |
Inhalation |
Nasal Cavity
|
Some Evidence |
Some Evidence |
squamous cell carcinoma (0/50, 0/50, 0/50, 3/50); squamous cell papilloma or carcinoma (0/50, 0/50, 0/50, 4/50)
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Female |
Topical Application |
Clitoral Gland
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 1/50 3/50 OR ADENOCARCINOMA 0/50 0/50 3/50 COMBINED 0/50 1/50 6/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Female |
Topical Application |
Esophagus
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 9/50 38/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Male |
Topical Application |
Esophagus
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 19/50 33/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Mice |
B6C3F1 |
Female |
Topical Application |
Forestomach
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 12/49 17/50 OR SQUAMOUS CELL CARCINOMA 0/50 7/47 6/50 COMBINED 0/50 18/49 19/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Mice |
B6C3F1 |
Male |
Topical Application |
Forestomach
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 12/50 20/50 OR SQUAMOUS CELL CARCINOMA 0/50 2/50 1/49 COMBINED 0/50 14/50 21/49
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Female |
Topical Application |
Forestomach
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 1/50 3/50 23/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Male |
Topical Application |
Forestomach
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 1/50 17/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Female |
Topical Application |
Intestines (Large)
|
Clear Evidence |
Clear Evidence |
ADENOCARCINOMA 0/50 3/50 4/49; ADENOMATOUS POLYP 0/50 12/50 37/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Male |
Topical Application |
Intestines (Large)
|
Clear Evidence |
Clear Evidence |
ADENOCARCINOMA 0/50 8/50 11/50; ADENOMATOUS POLYP 1/50 13/50 29/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Female |
Topical Application |
Kidney Tubular Cell
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 1/50 4/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Male |
Topical Application |
Kidney Tubular Cell
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 0/50 4/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Mice |
B6C3F1 |
Male |
Topical Application |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 1/50 2/50 9/50 OR CARCINOMA 0/50 0/50 3/50 COMBINED 1/50 2/50 11/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Female |
Topical Application |
Liver
|
Clear Evidence |
Clear Evidence |
NEOPLASTIC NODULES 0/50 10/50 11/50 OR CARCINOMA 0/50 2/50 6/50 COMBINED 0/50 11/50 14/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Male |
Topical Application |
Liver
|
Clear Evidence |
Clear Evidence |
NEOPLASTIC NODULES 0/49 3/50 2/50 OR CARCINOMA 0/49 1/50 3/50 COMBINED 0/49 4/50 5/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Mice |
B6C3F1 |
Female |
Topical Application |
Lung
|
Clear Evidence |
Equivocal Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 0/50 3/50 4/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 1/50 0/50 0/50 COMBINED 1/50 3/50 4/50
|
May Have Been Related
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Mice |
B6C3F1 |
Male |
Topical Application |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 1/50 1/50 6/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Female |
Topical Application |
Mammary Gland
|
Clear Evidence |
Clear Evidence |
ADENOCARCINOMA 0/50 0/50 5/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Male |
Topical Application |
Mesothelium (Abdominal Cavity/Tunica Vaginalis)
|
Clear Evidence |
Clear Evidence |
0/50 1/50 4/50
|
Neoplastic Lesions
|
Yes
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Female |
Topical Application |
Nasal Cavity
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 44/50 49/50
|
Neoplastic Lesions
|
Yes
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Male |
Topical Application |
Nasal Cavity
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 48/50 48/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Female |
Topical Application |
Oral Cavity
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 27/50 41/50 OR SQUAMOUS CELL CARCINOMA 0/50 15/50 27/50 COMBINED 0/50 39/50 49/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Male |
Topical Application |
Oral Cavity
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 40/50 33/50 OR SQUAMOUS CELL CARCINOMA 0/50 16/50 25/50 COMBINED 0/50 47/50 48/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Mice |
B6C3F1 |
Female |
Topical Application |
Skin
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 1/50 5/50 OR SQUAMOUS CELL CARCINOMA 0/50 0/50 1/50 COMBINED 0/50 1/50 6/50; SEBACEOUS GLAND ADENOMA 0/50 3/50 2/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Mice |
B6C3F1 |
Male |
Topical Application |
Skin
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 3/50 9/50 OR SQUAMOUS CELL CARCINOMA 0/50 0/50 2/50 COMBINED 0/50 3/50 11/50; SEBACEOUS GLAND ADENOMA 0/50 1/50 8/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Female |
Topical Application |
Skin
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 0/50 2/50 OR SQUAMOUS CELL CARCINOMA 0/50 0/50 1/50 COMBINED 0/50 0/50 3/50; BASAL CELL NEOPLASMS, SEBACEOUS GLAND ADENOMA OR KERATOACANTHOMA 0/50 3/50 18/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Male |
Topical Application |
Skin
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 1/50 3/50 0/50 OR SQUAMOUS CELL CARCINOMA 0/50 5/50 8/50 COMBINED 1/50 8/50 8/50; BASAL CELL NEOPLASMS, SEBACEOUS GLAND ADENOMA, OR KERATOACANTHOMA 0/50 20/50 31/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Male |
Topical Application |
Vascular System (Spleen)
|
Clear Evidence |
Clear Evidence |
HEMANGIOMA 0/50 0/50 3/50 OR HEMANGIOSARCOMA 0/50 0/50 1/50 COMBINED 0/50 0/50 4/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Female |
Topical Application |
Zymbal Gland
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 7/50 3/50 OR ADENOCARCINOMA 1/50 2/50 19/50 COMBINED 1/50 9/50 22/50
|
Neoplastic Lesions
|
No
|
TR-400
|
96-13-9 |
2,3-Dibromo-1-propanol |
Rats |
F344/N |
Male |
Topical Application |
Zymbal Gland
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 1/50 7/50 OR ADENOCARCINOMA 0/50 8/50 29/50 COMBINED 0/50 9/50 35/50
|
Neoplastic Lesions
|
No
|
TR-278
|
87-62-7 |
2,6-Xylidine |
Rats |
CD |
Female |
Dosed-Feed |
Liver
|
Positive |
Equivocal Evidence |
NEOPLASTIC NODULE 0/56 1/56 2/56 4/56
|
May Have Been Related
|
Yes
|
TR-278
|
87-62-7 |
2,6-Xylidine |
Rats |
CD |
Female |
Dosed-Feed |
Nasal Cavity
|
Positive |
Positive |
ADENOMA 0/56 0/56 1/56 6/56; CARCINOMA 0/56 0/56 1/56 24/56
|
Neoplastic Lesions
|
Yes
|
TR-278
|
87-62-7 |
2,6-Xylidine |
Rats |
CD |
Male |
Dosed-Feed |
Nasal Cavity
|
Positive |
Positive |
ADENOMA 0/56 0/56 2/56 10/56; CARCINOMA 0/56 0/56 0/56 26/56
|
Neoplastic Lesions
|
No
|
TR-278
|
87-62-7 |
2,6-Xylidine |
Rats |
CD |
Female |
Dosed-Feed |
Subcutaneous Tissue
|
Positive |
Equivocal Evidence |
FIBROMA 0/56 2/56 1/56 4/56; FIBROSARCOMA 1/56 0/56 1/56 3/56
|
May Have Been Related
|
No
|
TR-278
|
87-62-7 |
2,6-Xylidine |
Rats |
CD |
Male |
Dosed-Feed |
Subcutaneous Tissue
|
Positive |
Equivocal Evidence |
FIBROMA 0/56 1/56 2/56 4/56; FIBROSARCOMA 0/56 1/56 0/56 1/56
|
May Have Been Related
|
No
|
TR-376
|
106-92-3 |
Allyl glycidyl ether |
Mice |
B6C3F1 |
Female |
Inhalation |
Nasal Cavity
|
Equivocal Evidence |
Equivocal Evidence |
ADENOMA 0/49 0/49 1/50
|
Neoplastic Lesions
|
No
|
TR-376
|
106-92-3 |
Allyl glycidyl ether |
Rats |
Osborne Mendel |
Male |
Inhalation |
Nasal Cavity
|
Equivocal Evidence |
Equivocal Evidence |
ADENOMA 0/44 0/46 1/43; ADENOCARCINOMA 0/44 0/46 1/43; SQUAMOUS CELL CARCINOMA 0/44 0/46 1/43
|
Neoplastic Lesions
|
Yes
|
TR-376
|
106-92-3 |
Allyl glycidyl ether |
Mice |
B6C3F1 |
Male |
Inhalation |
Nasal Cavity
|
Some Evidence |
Some Evidence |
ADENOMA 0/50 0/50 3/50
|
Neoplastic Lesions
|
No
|
TR-542
|
98-82-8 |
Cumene |
Rats |
F344/N |
Male |
Inhalation |
Kidney Tubular Cell
|
Clear Evidence |
Clear Evidence |
renal tubule, adenoma or carcinoma (2/50, 5/50, 8/50, 7/50)
|
Neoplastic Lesions
|
No
|
TR-542
|
98-82-8 |
Cumene |
Mice |
B6C3F1/N |
Female |
Inhalation |
Liver
|
Clear Evidence |
Clear Evidence |
adenoma (18/50, 23/50, 27/50, 29/50); adenoma or carcinoma (25/50, 26/50, 29/50, 36/50)
|
Neoplastic Lesions
|
No
|
TR-542
|
98-82-8 |
Cumene |
Mice |
B6C3F1/N |
Female |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
alveolar/bronchiolar adenoma (1/50, 26/50, 36/50, 38/50); alveolar/bronchiolar carcinoma (3/50, 16/50, 20/50, 34/50); alveolar/bronchiolar adenoma or carcinoma (4/50, 31/50, 42/50, 46/50)
|
Neoplastic Lesions
|
No
|
TR-542
|
98-82-8 |
Cumene |
Mice |
B6C3F1/N |
Male |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
alveolar/bronchiolar adenoma (13/50, 31/50, 31/50, 29/50); alveolar/bronchiolar carcinoma (9/50, 19/50, 32/50, 33/50); alveolar/bronchiolar adenoma or carcinoma (19/50, 38/50, 42/50, 43/50)
|
Neoplastic Lesions
|
Yes
|
TR-542
|
98-82-8 |
Cumene |
Rats |
F344/N |
Male |
Inhalation |
Nasal Cavity
|
Clear Evidence |
Clear Evidence |
respiratory epithelium, adenoma (0/50, 7/50, 18/49, 10/50)
|
Neoplastic Lesions
|
Yes
|
TR-542
|
98-82-8 |
Cumene |
Rats |
F344/N |
Female |
Inhalation |
Nasal Cavity
|
Some Evidence |
Some Evidence |
respiratory epithelium, adenoma (0/50, 5/48, 4/50, 3/50)
|
Neoplastic Lesions
|
No
|
TR-542
|
98-82-8 |
Cumene |
Mice |
B6C3F1/N |
Male |
Inhalation |
Spleen
|
Clear Evidence |
Equivocal Evidence |
hemangioscaroma
|
May Have Been Related
|
No
|
TR-542
|
98-82-8 |
Cumene |
Rats |
F344/N |
Male |
Inhalation |
Testis
|
Clear Evidence |
Equivocal Evidence |
interstitial cell adenoma
|
May Have Been Related
|
No
|
TR-542
|
98-82-8 |
Cumene |
Mice |
B6C3F1/N |
Male |
Inhalation |
Thyroid Gland Follicular Cell
|
Clear Evidence |
Equivocal Evidence |
adenoma
|
May Have Been Related
|
No
|
TR-316
|
513-37-1 |
Dimethylvinyl chloride (DMVC) |
Rats |
F344/N |
Female |
Gavage |
Esophagus
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL CARCINOMA 0/49 3/50 1/49
|
Neoplastic Lesions
|
No
|
TR-316
|
513-37-1 |
Dimethylvinyl chloride (DMVC) |
Rats |
F344/N |
Male |
Gavage |
Esophagus
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 2/50 3/49 OR SQUAMOUS CELL CARCINOMA 0/50 4/50 1/49 COMBINED 0/50 6/50 4/49
|
Neoplastic Lesions
|
No
|
TR-316
|
513-37-1 |
Dimethylvinyl chloride (DMVC) |
Mice |
B6C3F1 |
Female |
Gavage |
Forestomach
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL CARCINOMA 0/50 40/47 36/43
|
Neoplastic Lesions
|
No
|
TR-316
|
513-37-1 |
Dimethylvinyl chloride (DMVC) |
Mice |
B6C3F1 |
Male |
Gavage |
Forestomach
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 1/48 3/47 8/44; SQUAMOUS CELL CARCINOMA 0/48 42/47 35/44
|
Neoplastic Lesions
|
No
|
TR-316
|
513-37-1 |
Dimethylvinyl chloride (DMVC) |
Rats |
F344/N |
Female |
Gavage |
Forestomach
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 1/50 4/50 1/49 OR SQUAMOUS CELL CARCINOMA 0/50 5/50 1/49 COMBINED 1/50 9/50 2/49
|
Neoplastic Lesions
|
No
|
TR-316
|
513-37-1 |
Dimethylvinyl chloride (DMVC) |
Rats |
F344/N |
Male |
Gavage |
Forestomach
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/49 7/50 0/50; SQUAMOUS CELL CARCINOMA 0/49 7/50 0/50
|
Neoplastic Lesions
|
Yes
|
TR-316
|
513-37-1 |
Dimethylvinyl chloride (DMVC) |
Rats |
F344/N |
Female |
Gavage |
Nasal Cavity
|
Clear Evidence |
Clear Evidence |
ADENOCARCINOMA 0/50 3/49 6/41; CARCINOMA 0/50 11/49 28/41; SQUAMOUS CELL CARCINOMA 0/50 2/49 2/41
|
Neoplastic Lesions
|
Yes
|
TR-316
|
513-37-1 |
Dimethylvinyl chloride (DMVC) |
Rats |
F344/N |
Male |
Gavage |
Nasal Cavity
|
Clear Evidence |
Clear Evidence |
ADENOCARCINOMA 0/47 8/46 4/32; CARCINOMA 0/47 12/46 24/32; SQUAMOUS CELL CARCINOMA 0/47 3/46 0/32
|
Neoplastic Lesions
|
No
|
TR-316
|
513-37-1 |
Dimethylvinyl chloride (DMVC) |
Rats |
F344/N |
Female |
Gavage |
Oral Cavity
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 0/50 4/50 OR SQUAMOUS CELL CARCINOMA 0/50 2/50 1/50 COMBINED 0/50 2/50 5/50
|
Neoplastic Lesions
|
No
|
TR-316
|
513-37-1 |
Dimethylvinyl chloride (DMVC) |
Rats |
F344/N |
Male |
Gavage |
Oral Cavity
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 0/50 2/50 OR SQUAMOUS CELL CARCINOMA 0/50 5/50 2/50 COMBINED 0/50 5/50 4/50
|
Neoplastic Lesions
|
No
|
TR-316
|
513-37-1 |
Dimethylvinyl chloride (DMVC) |
Mice |
B6C3F1 |
Male |
Gavage |
Preputial Gland
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL CARCINOMA 1/48 3/47 16/44
|
Neoplastic Lesions
|
No
|
TR-482
|
98-00-0 |
Furfuryl alcohol |
Rats |
F344/N |
Female |
Inhalation |
Kidney Tubular Cell
|
Equivocal Evidence |
Equivocal Evidence |
ADENOMA (SINGLE AND STEP SECTIONS) COMBINED 0/50 1/49 2/49 2/50
|
May Have Been Related
|
No
|
TR-482
|
98-00-0 |
Furfuryl alcohol |
Mice |
B6C3F1 |
Male |
Inhalation |
Kidney Tubular Cell
|
Some Evidence |
Some Evidence |
(SINGLE SECTIONS) ADENOMA 0/50 0/49 049 2/50 OR CARCINOMA 0/50 0/49 0/49 2/50 COMBINED 0/50 0/49 0/49 4/50; (SINGLE AND STEP SECTIONS) ADENOMA 0/50 0/49 0/49 3/50 COMBINED 0/50 0/49 0/49 5/50
|
Neoplastic Lesions
|
No
|
TR-482
|
98-00-0 |
Furfuryl alcohol |
Rats |
F344/N |
Female |
Inhalation |
Nasal Cavity
|
Equivocal Evidence |
Equivocal Evidence |
RESPIRATORY EPITHELIUM ADENOMA 0/49 0/50 0/48 1/49; LATERAL WALL ADENOMA 0/49 0/50 1/48 0/49
|
May Have Been Related
|
Yes
|
TR-482
|
98-00-0 |
Furfuryl alcohol |
Rats |
F344/N |
Male |
Inhalation |
Nasal Cavity
|
Some Evidence |
Some Evidence |
ADENOMA, CARCINOMA, OR SQUAMOUS CELL CARCINOMA 0/50 1/50 1/50 4/50
|
Neoplastic Lesions
|
No
|
TR-578
|
90045-36-6 |
Ginkgo biloba extract |
Rats |
F344/N |
Male |
Gavage |
All Organs
|
Some Evidence |
Equivocal Evidence |
Mononuclear Cell Leukemia 9/50, 12/50, 22/50, 21/50
|
May Have Been Related
|
No
|
TR-578
|
90045-36-6 |
Ginkgo biloba extract |
Rats |
F344/N |
Male |
Gavage |
Liver
|
Some Evidence |
Equivocal Evidence |
hepatocellular adenoma 0/50, 3/50, 3/50, 0/50
|
May Have Been Related
|
No
|
TR-578
|
90045-36-6 |
Ginkgo biloba extract |
Mice |
B6C3F1/N |
Female |
Gavage |
Liver
|
Clear Evidence |
Clear Evidence |
hepatocellular adenoma 17/50, 37/50, 41/50, 48/50; hepatocellular carcinoma 9/50, 10/50, 15/50, 44/50; hepatoblastoma 1/50, 1/50, 8/50, 11/50
|
Neoplastic Lesions
|
No
|
TR-578
|
90045-36-6 |
Ginkgo biloba extract |
Mice |
B6C3F1/N |
Male |
Gavage |
Liver
|
Clear Evidence |
Clear Evidence |
hepatocellular carcinoma 22/50, 31/50, 41/50, 47/50; hepatoblastoma 3/50, 28/50, 36/50, 38/50
|
Neoplastic Lesions
|
Yes
|
TR-578
|
90045-36-6 |
Ginkgo biloba extract |
Rats |
F344/N |
Female |
Gavage |
Nasal Cavity
|
Some Evidence |
Equivocal Evidence |
respiratory epithelium, adenoma 0/49, 0/49, 2/50, 0/46
|
May Have Been Related
|
No
|
TR-578
|
90045-36-6 |
Ginkgo biloba extract |
Mice |
B6C3F1/N |
Male |
Gavage |
Thyroid Gland Follicular Cell
|
Clear Evidence |
Clear Evidence |
adenoma 0/50, 0/50, 2/50, 2/50
|
Neoplastic Lesions
|
No
|
TR-578
|
90045-36-6 |
Ginkgo biloba extract |
Rats |
F344/N |
Female |
Gavage |
Thyroid Gland Follicular Cell
|
Some Evidence |
Some Evidence |
adenoma 1/49, 0/50, 3/49, 1/49; follicular cell, carcinoma 0/49, 0/50, 1/49, 1/49
|
Neoplastic Lesions
|
No
|
TR-578
|
90045-36-6 |
Ginkgo biloba extract |
Rats |
F344/N |
Male |
Gavage |
Thyroid Gland Follicular Cell
|
Some Evidence |
Some Evidence |
adenoma 2/50, 1/50, 3/49, 5/45
|
Neoplastic Lesions
|
No
|
TR-340
|
5634-39-9 |
Iodinated glycerol |
Mice |
B6C3F1 |
Female |
Gavage |
Forestomach
|
Some Evidence |
Equivocal Evidence |
SQUAMOUS CELL PAPILLOMA 1/49 2/50 5/49
|
May Have Been Related
|
No
|
TR-340
|
5634-39-9 |
Iodinated glycerol |
Mice |
B6C3F1 |
Female |
Gavage |
Harderian Gland
|
Some Evidence |
Some Evidence |
ADENOMA 6/50 8/40 13/50 OR CARCINOMA 0/50 0/40 1/50 COMBINED 6/50 8/40 14/50
|
Neoplastic Lesions
|
No
|
TR-340
|
5634-39-9 |
Iodinated glycerol |
Rats |
F344/N |
Male |
Gavage |
Hematopoietic System
|
Some Evidence |
Some Evidence |
LEUKEMIA 14/50 29/50 24/50
|
Neoplastic Lesions
|
Yes
|
TR-340
|
5634-39-9 |
Iodinated glycerol |
Rats |
F344/N |
Male |
Gavage |
Nasal Cavity
|
Some Evidence |
Equivocal Evidence |
ADENOMA 0/48 0/47 2/49
|
May Have Been Related
|
No
|
TR-340
|
5634-39-9 |
Iodinated glycerol |
Mice |
B6C3F1 |
Female |
Gavage |
Pituitary Gland
|
Some Evidence |
Some Evidence |
ADENOMA 10/47 15/45 24/46
|
Neoplastic Lesions
|
No
|
TR-340
|
5634-39-9 |
Iodinated glycerol |
Rats |
F344/N |
Male |
Gavage |
Thyroid Gland Follicular Cell
|
Some Evidence |
Some Evidence |
CARCINOMA 0/49 5/49 1/49
|
Neoplastic Lesions
|
No
|
TR-579
|
99-97-8 |
N,N-Dimethyl-p-toluidine |
Mice |
B6C3F1/N |
Female |
Gavage |
Forestomach
|
Clear Evidence |
Clear Evidence |
squamous cell papilloma 1/50, 5/50, 6/50, 7/50; squamous cell papilloma or carcinoma 1/50, 6/50, 6/50, 7/50
|
Neoplastic Lesions
|
No
|
TR-579
|
99-97-8 |
N,N-Dimethyl-p-toluidine |
Mice |
B6C3F1/N |
Female |
Gavage |
Liver
|
Clear Evidence |
Clear Evidence |
hepatocellular adenoma 17/50, 19/50, 37/50, 44/50; hepatocellular carcinoma 6/50, 13/50, 18/50, 31/50; hepatoblastoma 0/50, 1/50, 0/50, 4/50
|
Neoplastic Lesions
|
No
|
TR-579
|
99-97-8 |
N,N-Dimethyl-p-toluidine |
Mice |
B6C3F1/N |
Male |
Gavage |
Liver
|
Clear Evidence |
Clear Evidence |
hepatocellular adenoma, multiple 17/50, 19/50, 27/50, 26/50; hepatocellular carcinoma 22/50, 25/50, 30/50, 36/50; hepatoblastoma 1/50, 5/50, 10/50, 8/50
|
Neoplastic Lesions
|
No
|
TR-579
|
99-97-8 |
N,N-Dimethyl-p-toluidine |
Rats |
F344/N |
Female |
Gavage |
Liver
|
Clear Evidence |
Clear Evidence |
hepatocellular carcinoma 0/50, 0/50, 0/50, 4/49; hepatocellular adenoma or carcinoma 0/50, 1/50, 1/50, 7/49
|
Neoplastic Lesions
|
No
|
TR-579
|
99-97-8 |
N,N-Dimethyl-p-toluidine |
Rats |
F344/N |
Male |
Gavage |
Liver
|
Clear Evidence |
Clear Evidence |
hepatocellular carcinoma 0/50, 0/50, 1/50, 6/50; hepatocellular adenoma or carcinoma 0/50, 0/50, 2/50, 6/50
|
Neoplastic Lesions
|
No
|
TR-579
|
99-97-8 |
N,N-Dimethyl-p-toluidine |
Mice |
B6C3F1/N |
Female |
Gavage |
Lung
|
Clear Evidence |
Clear Evidence |
alveolar/bronchiolar adenoma 2/50, 4/50, 8/50, 12/50; alveolar/bronchiolar adenoma or carcinoma 2/50, 5/50, 9/50, 13/50
|
Neoplastic Lesions
|
Yes
|
TR-579
|
99-97-8 |
N,N-Dimethyl-p-toluidine |
Rats |
F344/N |
Female |
Gavage |
Nasal Cavity
|
Clear Evidence |
Clear Evidence |
transitional epithelium, adenoma 0/50, 1/49, 0/50, 2/49
|
Neoplastic Lesions
|
Yes
|
TR-579
|
99-97-8 |
N,N-Dimethyl-p-toluidine |
Rats |
F344/N |
Male |
Gavage |
Nasal Cavity
|
Clear Evidence |
Clear Evidence |
transitional epithelium, adenoma 0/50, 3/49, 2/50, 11/49; transitional epithelium, adenoma or carcinoma 0/50, 3/49, 2/50, 13/49
|
Neoplastic Lesions
|
No
|
TR-579
|
99-97-8 |
N,N-Dimethyl-p-toluidine |
Rats |
F344/N |
Male |
Gavage |
Thyroid Gland Follicular Cell
|
Clear Evidence |
Equivocal Evidence |
adenoma or carcinoma 1/50, 2/49, 2/50, 4/49
|
May Have Been Related
|
Yes
|
TR-500
|
91-20-3 |
Naphthalene |
Rats |
F344/N |
Female |
Inhalation |
Nasal Cavity
|
Clear Evidence |
Clear Evidence |
(RESPIRATORY EPITHELIUM) ADENOMA 0/49 0/49 4/49 2/49 (OLFACTORY EPITHELIUM) NEUROBLASTOMA 0/49 2/49 3/49 12/49
|
Neoplastic Lesions
|
Yes
|
TR-500
|
91-20-3 |
Naphthalene |
Rats |
F344/N |
Male |
Inhalation |
Nasal Cavity
|
Clear Evidence |
Clear Evidence |
(RESPIRATORY EPITHELIUM) ADENOMA 0/49 6/49 8/48 15/48 (OLFACTORY EPITHELIUM) NEUROBLASTOMA 0/49 0/49 4/48 3/48
|
Neoplastic Lesions
|
No
|
TR-142
|
120-71-8 |
p-Cresidine |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Liver
|
Positive |
Positive |
(CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-142
|
120-71-8 |
p-Cresidine |
Rats |
F344/N |
Male |
Dosed-Feed |
Liver
|
Positive |
Positive |
(NEOPLASTIC NODULE OR CARCINOMA)
|
Neoplastic Lesions
|
Yes
|
TR-142
|
120-71-8 |
p-Cresidine |
Rats |
F344/N |
Female |
Dosed-Feed |
Nasal Cavity
|
Positive |
Positive |
(NEUROBLASTOMA)
|
Neoplastic Lesions
|
Yes
|
TR-142
|
120-71-8 |
p-Cresidine |
Rats |
F344/N |
Male |
Dosed-Feed |
Nasal Cavity
|
Positive |
Positive |
(NEUROBLASTOMA)
|
Neoplastic Lesions
|
No
|
TR-142
|
120-71-8 |
p-Cresidine |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Urinary Bladder
|
Positive |
Positive |
(CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-142
|
120-71-8 |
p-Cresidine |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Urinary Bladder
|
Positive |
Positive |
(CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-142
|
120-71-8 |
p-Cresidine |
Rats |
F344/N |
Female |
Dosed-Feed |
Urinary Bladder
|
Positive |
Positive |
(PAPILLOMA, CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-142
|
120-71-8 |
p-Cresidine |
Rats |
F344/N |
Male |
Dosed-Feed |
Urinary Bladder
|
Positive |
Positive |
(PAPILLOMA, CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-483
|
87-86-5 |
Pentachlorophenol, purified |
Rats |
F344/N |
Female |
Dosed-Feed |
Unspecified
|
No Evidence |
|
Not applicable
|
Not applicable
|
No
|
TR-483
|
87-86-5 |
Pentachlorophenol, purified |
Rats |
F344/N |
Male |
Dosed-Feed |
Mesothelium (Abdominal Cavity/Tunica Vaginalis)
|
Some Evidence |
Some Evidence |
MESOTHELIOMA 1/50 0/50 2/50 0/50 9/50 (STOP STUDY)
|
Neoplastic Lesions
|
Yes
|
TR-483
|
87-86-5 |
Pentachlorophenol, purified |
Rats |
F344/N |
Male |
Dosed-Feed |
Nasal Cavity
|
Some Evidence |
Some Evidence |
CARCINOMA 1/50 3/50 1/50 0/50 5/50 (STOP STUDY)
|
Neoplastic Lesions
|
No
|
TR-552
|
107-19-7 |
Propargyl alcohol |
Mice |
B6C3F1/N |
Male |
Inhalation |
Harderian Gland
|
Some Evidence |
Equivocal Evidence |
adenoma 3/50, 10/50, 6/50, 11/50
|
May Have Been Related
|
Yes
|
TR-552
|
107-19-7 |
Propargyl alcohol |
Mice |
B6C3F1/N |
Female |
Inhalation |
Nasal Cavity
|
Some Evidence |
Some Evidence |
adenoma, respiratory epithelium (0/50, 2/50, 4/50, 6/50)
|
Neoplastic Lesions
|
Yes
|
TR-552
|
107-19-7 |
Propargyl alcohol |
Mice |
B6C3F1/N |
Male |
Inhalation |
Nasal Cavity
|
Some Evidence |
Some Evidence |
adenoma, respiratory epithelium (0/49, 1/50, 4/50, 7/50)
|
Neoplastic Lesions
|
Yes
|
TR-552
|
107-19-7 |
Propargyl alcohol |
Rats |
F344/N |
Male |
Inhalation |
Nasal Cavity
|
Some Evidence |
Some Evidence |
adenoma, respiratory epithelium (0/49, 0/49, 0/50, 3/49)
|
Neoplastic Lesions
|
No
|
TR-582
|
75-35-4 |
Vinylidene Chloride |
Rats |
F344/N |
Female |
Inhalation |
All Organs
|
Some Evidence |
Equivocal Evidence |
malignant mesothelioma 0/50 1/50 1/50 0/50
|
May Have Been Related
|
No
|
TR-582
|
75-35-4 |
Vinylidene Chloride |
Mice |
B6C3F1/N |
Female |
Inhalation |
All Organs
|
Clear Evidence |
Clear Evidence |
hemangioma or hemangiosarcoma 4/50 6/50 6/50 11/50
|
Neoplastic Lesions
|
No
|
TR-582
|
75-35-4 |
Vinylidene Chloride |
Rats |
F344/N |
Male |
Inhalation |
All Organs
|
Clear Evidence |
Clear Evidence |
malignant mesothelioma 1/50 12/50 28/50 23/50
|
Neoplastic Lesions
|
No
|
TR-582
|
75-35-4 |
Vinylidene Chloride |
Rats |
F344/N |
Female |
Inhalation |
All Organs
|
Some Evidence |
Some Evidence |
mononuclear cell leukemia 10/50 11/50 13/50 25/50
|
Neoplastic Lesions
|
No
|
TR-582
|
75-35-4 |
Vinylidene Chloride |
Mice |
B6C3F1/N |
Female |
Inhalation |
Intestines (Small)
|
Clear Evidence |
Equivocal Evidence |
(Duodenum, Jejunum, or Ileum): carcinoma 1/50 1/50 1/50 3/50
|
May Have Been Related
|
No
|
TR-582
|
75-35-4 |
Vinylidene Chloride |
Mice |
B6C3F1/N |
Male |
Inhalation |
Kidney
|
Clear Evidence |
Clear Evidence |
renal tubule adenoma 0/50 5/50 19/50 10/50 renal tubule carcinoma 0/50 7/50 31/50 18/50 renal tubule adenoma or carcinoma 0/50 11/50 37/50 27/50
|
Neoplastic Lesions
|
No
|
TR-582
|
75-35-4 |
Vinylidene Chloride |
Rats |
F344/N |
Male |
Inhalation |
Kidney
|
Clear Evidence |
Clear Evidence |
renal tubule carcinoma 0/50 2/50 1/49 1/50
|
Neoplastic Lesions
|
No
|
TR-582
|
75-35-4 |
Vinylidene Chloride |
Mice |
B6C3F1/N |
Male |
Inhalation |
Liver
|
Clear Evidence |
Equivocal Evidence |
hepatocholangiocarcionoma 1/50 2/50 2/50 3/50
|
May Have Been Related
|
No
|
TR-582
|
75-35-4 |
Vinylidene Chloride |
Mice |
B6C3F1/N |
Female |
Inhalation |
Liver
|
Clear Evidence |
Clear Evidence |
hepatocellular adenoma 25/50 21/50 36/50 29/50 hepatocellular carcinoma 8/50 14/50 12/50 17/50 hepatocellular adenoma or carcinoma 28/50 30/50 37/50 38/50 hepatocholangiocarcinoma 0/50 1/50 1/50 2/50
|
Neoplastic Lesions
|
No
|
TR-582
|
75-35-4 |
Vinylidene Chloride |
Mice |
B6C3F1/N |
Female |
Inhalation |
Lung
|
Clear Evidence |
Equivocal Evidence |
alveolar/bronchiolar carcinoma 1/50 2/50 7/50 5/49
|
May Have Been Related
|
Yes
|
TR-582
|
75-35-4 |
Vinylidene Chloride |
Rats |
F344/N |
Male |
Inhalation |
Nasal Cavity
|
Clear Evidence |
Clear Evidence |
respiratory epithelium, adenoma 0/49 0/50 1/50 4/50
|
Neoplastic Lesions
|
No
|
TR-582
|
75-35-4 |
Vinylidene Chloride |
Rats |
F344/N |
Female |
Inhalation |
Thyroid Gland C-Cell
|
Some Evidence |
Some Evidence |
adenoma 3/50 4/50 6/48 11/50; carcinoma 0/50 6/50 2/48 2/50 adenoma or carcinoma 3/50 10/50 8/48 13/50
|
Neoplastic Lesions
|